Inhibitors of the PLK1 polo-box domain: drug design strategies and therapeutic opportunities in cancer.
Inhibitors of the PLK1 polo-box domain: drug design strategies and therapeutic opportunities in cancer. Expert Opin Drug Discov. 2023 01; 18(1):65-81.